Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?
Objective: To describe the clinical characteristics and outcomes to the treatment of patients with isoniazid-resistant tuberculosis (Hr-TB) in an institution in southwest Colombia. Materials and methods: A retrospective observational study was conducted. Patients with diagnostic confirmation, micr...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Asociación Colombiana de Infectología
2020-04-01
|
Series: | Infectio |
Subjects: | |
Online Access: | https://www.revistainfectio.org/index.php/infectio/article/view/863 |
id |
doaj-7cc5608b9152445ab9a7923d6fbf020a |
---|---|
record_format |
Article |
spelling |
doaj-7cc5608b9152445ab9a7923d6fbf020a2020-11-25T03:58:23ZengAsociación Colombiana de InfectologíaInfectio0123-93922020-04-0124317318110.22354/in.v24i3.863Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?José Fernando García-Goez0 Fundación Valle del Lili, Departamento de Medicina Interna, Servicio de Enfermedades Infecciosas; Universidad Icesi, Facultad de Ciencias de la SaludObjective: To describe the clinical characteristics and outcomes to the treatment of patients with isoniazid-resistant tuberculosis (Hr-TB) in an institution in southwest Colombia. Materials and methods: A retrospective observational study was conducted. Patients with diagnostic confirmation, microbiological isolation, drug susceptibility tests, and evidence of Hr-TB were included. Results: Thirty-two patients with Hr-TB were included between 2006-2018, corresponding to 6% (32/528) of resistance in total cases. 78% were new cases, primary resistance, and 22% previously treated, acquired resistance. The most frequent comorbidity was HIV infection (n = 9). The pattern of Hr-TB showed in 23 (72%) cases with high level, 4 (12%) of low level and 5 (16%) with low and high level. The analysis of treatment results was performed on 22 patients, presenting 50% cure, 41% completed treatment, and 9% death related to tuberculosis. Conclusions: Hr-TB predominates in new cases, which is an obstacle to treatment where susceptibility tests are not performed routinely. https://www.revistainfectio.org/index.php/infectio/article/view/863mycobacterium tuberculosistuberculosisisoniazidmicrobial drug resistance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
José Fernando García-Goez |
spellingShingle |
José Fernando García-Goez Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia? Infectio mycobacterium tuberculosis tuberculosis isoniazid microbial drug resistance |
author_facet |
José Fernando García-Goez |
author_sort |
José Fernando García-Goez |
title |
Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia? |
title_short |
Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia? |
title_full |
Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia? |
title_fullStr |
Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia? |
title_full_unstemmed |
Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia? |
title_sort |
una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en colombia? |
publisher |
Asociación Colombiana de Infectología |
series |
Infectio |
issn |
0123-9392 |
publishDate |
2020-04-01 |
description |
Objective: To describe the clinical characteristics and outcomes to the treatment of patients with isoniazid-resistant tuberculosis (Hr-TB) in an institution in
southwest Colombia.
Materials and methods: A retrospective observational study was conducted. Patients with diagnostic confirmation, microbiological isolation, drug susceptibility
tests, and evidence of Hr-TB were included.
Results: Thirty-two patients with Hr-TB were included between 2006-2018, corresponding to 6% (32/528) of resistance in total cases. 78% were new cases, primary
resistance, and 22% previously treated, acquired resistance. The most frequent comorbidity was HIV infection (n = 9). The pattern of Hr-TB showed in 23 (72%) cases with high level, 4 (12%) of low level and 5 (16%) with low and high level. The analysis of treatment results was performed on 22 patients, presenting 50% cure, 41% completed treatment, and 9% death related to tuberculosis.
Conclusions: Hr-TB predominates in new cases, which is an obstacle to treatment where susceptibility tests are not performed routinely.
|
topic |
mycobacterium tuberculosis tuberculosis isoniazid microbial drug resistance |
url |
https://www.revistainfectio.org/index.php/infectio/article/view/863 |
work_keys_str_mv |
AT josefernandogarciagoez unaaproximacionalatuberculosisresistenteaisoniazidaunproblemasubestimadoencolombia |
_version_ |
1724457498188972032 |